These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9643679)
21. [Prevention of breast cancer using tamoxifen]. Foidart JM; Colin C; Lifrange E Rev Med Liege; 1998 Apr; 53(4):225-6. PubMed ID: 9641022 [No Abstract] [Full Text] [Related]
22. Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective. Goldhaber SZ Circulation; 2005 Feb; 111(5):539-41. PubMed ID: 15699272 [No Abstract] [Full Text] [Related]
23. Tamoxifen and prevention of breast cancer. Sherman JD Toxicol Ind Health; 1998; 14(4):485-99. PubMed ID: 9664641 [No Abstract] [Full Text] [Related]
24. Tamoxifen chemoprevention--are we throwing out the baby with the bathwater? Greenspan EM Cancer Invest; 1994; 12(6):671-5. PubMed ID: 7994603 [No Abstract] [Full Text] [Related]
25. Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Love RR J Natl Cancer Inst; 1999 Nov; 91(21):1891-2. PubMed ID: 10547398 [No Abstract] [Full Text] [Related]
26. Update on breast cancer prevention. Rastogi P; Vogel VG Oncology (Williston Park); 2003 Jun; 17(6):799-805; discussion 808-10, 813. PubMed ID: 12846124 [TBL] [Abstract][Full Text] [Related]
27. Clear thinking on tamoxifen. Johns Hopkins Med Lett Health After 50; 1998 Jul; 10(5):1-2. PubMed ID: 9650523 [No Abstract] [Full Text] [Related]
28. Tamoxifen for the prevention of breast cancer. Greenspan EM Am J Med; 1996 Jun; 100(6):665. PubMed ID: 8678089 [No Abstract] [Full Text] [Related]
29. [Chemoprevention of breast cancer by tamoxifen: should we still ask this question?]. Sasco AJ Rev Epidemiol Sante Publique; 1999 Jun; 47(3):279-85. PubMed ID: 10422121 [TBL] [Abstract][Full Text] [Related]
30. Give us clear, not convoluted, clinical practice guidelines. Sehmer J CMAJ; 2001 Nov; 165(11):1468-9. PubMed ID: 11762568 [No Abstract] [Full Text] [Related]
31. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point. Jordan VC Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908 [No Abstract] [Full Text] [Related]
32. Raloxifene works as well as tamoxifen in preventing invasive breast cancer. Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270 [No Abstract] [Full Text] [Related]
33. An overview of considerations for the testing of tamoxifen as a preventive for breast cancer. Jordan VC Ann N Y Acad Sci; 1995 Sep; 768():141-7. PubMed ID: 8526343 [No Abstract] [Full Text] [Related]
34. Tamoxifen chemoprevention: public health goals, toxicities for all and benefits to a few. Love RR Ann Oncol; 1995 Feb; 6(2):127-8. PubMed ID: 7786819 [No Abstract] [Full Text] [Related]
35. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint. Fabian C Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909 [No Abstract] [Full Text] [Related]
36. Cancer prevention or drug promotion? Journalists mishandle the tamoxifen story. Poe A Int J Health Serv; 1999; 29(3):657-61. PubMed ID: 10450552 [TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolic disease and stroke in women taking tamoxifen for breast cancer chemoprevention. Isaacs C Clin Adv Hematol Oncol; 2005 Dec; 3(12):913-4. PubMed ID: 16555431 [No Abstract] [Full Text] [Related]
38. Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention. Goldenberg VK; Seewaldt VL; Scott V; Bean GR; Broadwater G; Fabian C; Kimler B; Zalles C; Lipkus IM Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1032-4. PubMed ID: 17507634 [TBL] [Abstract][Full Text] [Related]
39. Tamoxifen's trials and tribulations. Marshall E Science; 1995 Nov; 270(5238):910. PubMed ID: 7481787 [No Abstract] [Full Text] [Related]
40. Aromatase inhibitors and breast cancer prevention. Litton JK; Arun BK; Brown PH; Hortobagyi GN Expert Opin Pharmacother; 2012 Feb; 13(3):325-31. PubMed ID: 22242911 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]